The global nootropics market is anticipated to grow at a CAGR of 14.1% during the forecast period (2023-2030). New and effective product launches is anticipated to drive the demand for nootropics, thereby is driving the market growth. For instance, in March 2023, Beverage label Savvy launched a nootropic-infused beverage range designed to optimize cognitive performance. The beverage range is available in two variants: Savvy Coffee and Savvy Drink. Savvy Coffee comes in coffee pods and coffee powder, both with biodegradable compostable packaging.
Browse the full report description of “Nootropics Market Size, Share & Trends Analysis Report by Form (Capsules/ Tablets, Powder, and Drinks), and by Distribution Channel (Online and Offline) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/nootropics-market
Further, in October 2022, Southern California-based nootropics brand Troomy launched its product line of adaptogenic mushroom gummies. Formulated to help support a wide range of lifestyles and functional needs, Troomy Mushroom Gummies are available in a variety of super-powered mushroom blends and flavors. For focus, the company offers Lion's Mane Mushroom Gummies (Tangerine Passionfruit). For Boost, the company offers Cordyceps Mushroom Gummies (Lemon Lime); For Calmness, the company offers Reishi Mushroom Gummies (Pineapple Peach); For effective sleep, the company offers Reishi + Melatonin Gummies (Black Raspberry)
Furthermore, in August 2022, Snack brand Mindright has launched: a “first-of-its-kind” range of popped chips infused with brain-boosting nootropic ingredients. The latest range comes in three flavours – Chili Lime, Cinnamon Churro and Tumeric Ranch. The popped chips are made using the brand’s signature nootropic concoction, which features ginseng, lion’s mane and L-Theanine, as well as vitamins B6, B12 and antioxidants that benefit energy, mood and focus. The chips are made with 100% avocado oil, in place of traditional oils such as canola and soybean.
In May 2022, Solaray announced the launch of Solaray SharpMind: a collection of advanced nootropics expertly crafted with clinically backed nutrients, adaptogens and fermented organic mushrooms designed to support mental and emotional well-being. Five unique formula includes stress, energy, focus, mood, and sleep — offer targeted support for specific cognitive requirements.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Form
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., and Teva Pharmaceutical Industries Ltd. among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Nootropics Market Report Segment
By Form
By Distribution Channel
Global Nootropics Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/nootropics-market